Double concentration of olopatadine controls allergies all day

May 1, 2003
Mark B. Abelson, MD, CM, FRCS(C)

Dr. Abelson, a clinical associate professor at Harvard Medical School, Boston.

Cheryl Guttman

Steven J. Lichenstein, MD

Dr. Lichenstein, assistant clinical professor of ophthalmology, University of Louisville, and chairman, Section of Ophthalmology, American Academy of Pediatrics.

Wailea, HI-Olopatadine 0.2% (Patanol, Alcon) significantly reduced itching and redness for 24 hours, according to the results of a study presented at the annual meeting of the Western Society of Allergy, Asthma & Immunology.